Nedocromil calcium and use thereof in treatment of reversible ob

Details Nedocromil calcium and use thereof in treatment of reversible ob Nedocromil calcium and use thereof in treatment of reversible ob

1988-02-24

1989-07-18

Lee, Mary C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546 92, A61K 31435, C07D49100

Patent

active

048494275

ABSTRACT:
There are described a new compound, methods for its preparation and compositions containing it.
Calcium 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano[3,2-g]-quinoline-2,8-dic arboxylate is a novel compound and is useful in the treatment of reversible obstructive airways disease and/or the prevention or treatment of rhinitis.

Affiliated with

Also associated with

Rating

Nedocromil calcium and use thereof in treatment of reversible ob does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nedocromil calcium and use thereof in treatment of reversible ob, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nedocromil calcium and use thereof in treatment of reversible ob will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-172539